Biogen Idec Inc SWOT Analysis, USP & Competitors

Posted in Pharmaceuticals and Healthcare, Total Reads: 677
Advertisements

SWOT Analysis of Biogen Idec Inc with USP, Competition, STP (Segmentation, Targeting, Positioning) - Marketing Analysis

Biogen Idec Inc

Parent Company

Biogen Idec Inc

Category

Biotechnology

Sector

Healthcare

Tagline/ Slogan

Transforming Discovery into Care

USP

Robust pipeline

STP

Segment

Neurodegenerative, hematologic, and autoimmune diseases

Target Group

Patients with high unmet medical needs

Positioning

Leader in discovery, development, and delivery of therapies

SWOT Analysis

Strengths

1. High annual growth shows its strong business and high credibility 
2. Intellectual strength of renowned biologists

3. Worldwide presence in more than 90 countries
4. Financial muscle for overseas acquisition

5. Strong foothold in biosimilar drugs

6. Over 7000 people are employed with the organization

7. Strong focus on R&D and patenting products

Weaknesses

1. Limited global market share
2. Restricted brand awareness as compared to global healthcare brands

Opportunities

1. Rising demand from developing countries
2. Expansion into generics over biosimilars

3. Increased brand awareness exercises can boost the business globally

Threats

1. Ever changing regulatory rules in different countries across the world
2. Failure of new drugs in trial and testing cost company millions of dollars

Competition

Competitors

1. Bayer Pharma AG

2. Pfizer Inc
3. Bristol-Myers Squibb



Advertisements



Looking for More Brands? Search BrandGuide

Edit the Brand or Add a New One : Contribute to BrandGuide

The brandnames and other brand information used in the brandguide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only.
Utmost Care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.